Cafepharma

Portfolio

Lists

Sources

Guide

How would you rate this source in terms of content quality?

Similiar Sources

BioPharma Dive

Biotech - News 8.0

Biopharma Reporter

Biotech - News 8.0

Drug Delivery Business

Biotech - News 8.0

Drugs.com

Biotech - News 8.0

Evaluate

Biotech - News 8.0

Fierce Biotech

Biotech - News 8.0

GEN

Biotech - News 8.0

Labiotech

Biotech - News 8.0

Pharmafile

Biotech - News 8.0

PharmaLive

Biotech - News 8.0

Summary

Sector Biotech

Content Type News

Website Other

Paywall No

Ratings

Average Rating 8.0

Ratings 1

Your Rating Rate

Ranking 707

Content

Cafepharma

J&J oncology sales grow, but shares slide on outlook

Jan. 22, 2025, 5:01 p.m.

No Paywall

Cafepharma

Abbott's first-quarter profit forecast misses estimates, shares dip

Jan. 22, 2025, 4:59 p.m.

No Paywall

Cafepharma

Tris Pharma's alternative to opioids reduces post-surgery pain in phase 3 trial ahead of NDA submission

Jan. 22, 2025, 4:58 p.m.

No Paywall

Cafepharma

Project Stargate: A $500 Billion Venture Between Oracle, Open AI, Nvidia And Softbank That Could Revolutionize Healthcare

Jan. 22, 2025, 4:57 p.m.

No Paywall

Cafepharma

Novo Nordisk gets BACH1, inking IMMvention deal to orchestrate attack on sickle cell disease

Jan. 22, 2025, 4:55 p.m.

No Paywall

Cafepharma

Trump admin orders federal health agencies to halt communications

Jan. 22, 2025, 4:48 p.m.

No Paywall

Cafepharma

Biohybrid Devices: Healthcare's Latest Game-changer

Jan. 22, 2025, 4:38 p.m.

No Paywall

Cafepharma

After an obesity stumble, BioAge reconnects with its longevity pipeline

Jan. 22, 2025, 4:20 p.m.

No Paywall

Cafepharma

Takeda backs biomarker trial for Crohn's prevention

Jan. 22, 2025, 4:18 p.m.

No Paywall

Cafepharma

The Big Three PBMs’ 2025 Formulary Exclusions: Humira, Stelara, Private Labels, and the Shaky Future for Pharmacy Biosimilars

Jan. 22, 2025, 4:17 p.m.

No Paywall

Cafepharma

Large study of Novo, Lilly weight loss drugs shows decrease in risk of Alzheimer's

Jan. 22, 2025, 12:13 a.m.

No Paywall

Cafepharma

JPM25 Recap: The Medtech Moments That Have the Industry Buzzing

Jan. 22, 2025, 12:10 a.m.

No Paywall

Cafepharma

Sanofi API plant hit with FDA warning letter detailing quality, consistency flubs

Jan. 22, 2025, 12:08 a.m.

No Paywall

Cafepharma

Valneva announces positive outcomes from chikungunya vaccine trial

Jan. 22, 2025, 12:07 a.m.

No Paywall

Cafepharma

Moderna gets $590M from US government for bird flu vaccine

Jan. 22, 2025, 12:04 a.m.

No Paywall

Cafepharma

Sage sues Biogen as analyst detects little interest in buyout at original offer price

Jan. 22, 2025, 12:02 a.m.

No Paywall

Cafepharma

FDA approves Johnson & Johnson’s nasal spray for depression as standalone treatment

Jan. 21, 2025, 4:34 p.m.

No Paywall

Cafepharma

Ascletis Pharma’s ASC30 oral tablet shows promise in obesity trial

Jan. 21, 2025, 4:27 p.m.

No Paywall

Cafepharma

Boston Scientific sees success in PFA device trial

Jan. 21, 2025, 4:24 p.m.

No Paywall

Cafepharma

FDA gives Amylyx green light for phase 1 ALS trial after clinical hold

Jan. 21, 2025, 4:23 p.m.

No Paywall

Cafepharma

Where Will Moderna Be in 3 Years?

Jan. 21, 2025, 4:18 p.m.

No Paywall

Cafepharma

Sionna, Odyssey join queue of biotechs testing investors’ IPO interest

Jan. 21, 2025, 4:16 p.m.

No Paywall

Cafepharma

Disc set to spin up confirmatory trial, seek approval after ironing out details with FDA

Jan. 21, 2025, 4:15 p.m.

No Paywall

Cafepharma

Could OTC Cialis for erectile dysfunction reach the US?

Jan. 21, 2025, 4:11 p.m.

No Paywall

Cafepharma

EU approves endometrial, lung cancer drugs from GSK and J&J

Jan. 21, 2025, 4:10 p.m.

No Paywall

1 - 25 of 6161 Results

2 3

Add to your lists

Recommended Content

Cafepharma

Tags

Similiar Sources

Summary

Ratings

Content